News & Articles

North American Demo Lab will expand Covalent’s chemical analysis services and showcase HORIBA’s analytical instrumentation

Discover innovative POC technology designed to meet today’s emergency care needs and inform effective management of cardiac patients

Watch this on-demand webinar to find out how you can streamline residual solvent analysis according to USP

Amulet device is the first minimally invasive option approved for left atrial appendage occlusion that does not require blood-thinning medication

Watch this on-demand webinar to explore a complete workflow for the development of targeted biomarker measurements for precision medicine

Researchers announce the results of a study into thrombocytopenia and thromboembolic events following Covid-19 vaccination

A certain type of smile can help to restore trust in relationships after someone has been uncooperative or untrustworthy, according to new research by Queen’s University Belfast

In this guest article by RayBiotech Life, learn how ELISA and pseudoviruses enable COVID-19 drug development

R&D manager Yahya Nuruddeen supervises multiple research teams. Here, he explains how reviews have helped him make the right decision for their laboratories

Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant

Fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than 4 weeks, and almost all children have fully recovered by 8 weeks

From tackling COVID-19 variants to therapeutic discovery, novel organoids and more, advance your assay research with these exclusive interviews and free resources

Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis

The Simple Plex AAV2 assay combines the scalability and automation of Ella with best-in-class AAV reagents from PROGEN

The Synthetic Brain Project is using AI models powered by the Cambridge-1 supercomputer

Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models

Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment

Discover the impact of the COVID-19 pandemic on a clinical research facility and the future of clinical trial recruitment

The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients

Mixed schedules involving Pfizer-BioNTech and Oxford-AstraZeneca generate strong immune response against SARS-CoV2 spike IgG protein

Top talks and new resources detailing key developments in the fields of clinical research and diagnostics are now available on demand